The role of novel prognostic factors in treatment of patient witn spine metastases

Cover Page

Cite item

Full Text

Abstract

It performed the analysis of literature data on assessing cancer prognosis possibilities in patients with spine metastases. Surgical intervention for metastatic spinal lesions is palliative, but the majority of patients who undergo local treatment of a given volume in combination with systemic therapy, have improved their quality of life. It is noted that the adequate determination and use of prognostic factors in clinical practice in the planning of surgical treatment helps to determine spinal surgery volume and assess the life expectancy in this patients. It described the developed prognosis systems (Tokuhashi, Sioutos, Tomita, Van der Linden, Bauer), and it is indicated that these scales differ depending on the parameters included in them and do not take into account the options for systemic treatment of a malignant disease and the presence of mutations in the tumor. It was concluded that the treatment of spinal metastases should be individualized and multidisciplinary, the rational choice of treatment and its scope should be based on a comprehensive assessment of anamnestic, clinical and prognostic data. Accurate assessment of the postoperative survival prognosis will improve the quality of medical care for this category of patients and achieve optimal indicators of quality of life.

About the authors

A. V. Kulaga

FSBI «N.N. Blokhin National Medical Research Center of Oncology» оf the Health Ministry of Russia

Author for correspondence.
Email: roncspine@gmail.com
Russian Federation

E. R. Musaev

FSBI «N.N. Blokhin National Medical Research Center of Oncology» оf the Health Ministry of Russia

Russian Federation

A. K. Valiev

FSBI «N.N. Blokhin National Medical Research Center of Oncology» оf the Health Ministry of Russia

Russian Federation

K. A. Borzov

FSBI «N.N. Blokhin National Medical Research Center of Oncology» оf the Health Ministry of Russia

Russian Federation

R. M. Kabardaev

FSBI «N.N. Blokhin National Medical Research Center of Oncology» оf the Health Ministry of Russia

Russian Federation

M. D. Aliev

FSBI «N.N. Blokhin National Medical Research Center of Oncology» оf the Health Ministry of Russia

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Kulaga A.V., Musaev E.R., Valiev A.K., Borzov K.A., Kabardaev R.M., Aliev M.D.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.